phrykt

Veradermics, Inc (MANE): who owns it and who trades it

As of Nov 16, 2026, MANE insiders reported 16 open-market sales worth $141M and 23 purchases worth $34.8M in the last 12 months, with 9% of the sale value made under pre-set 10b5-1 plans. The largest seller was Averill Master Fund, Ltd. (Director), with $80.4M. 4 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Veradermics

From the latest filings

Overall: more buying than selling. Funds, insiders and famous investors mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns MANE

164 funds and institutions reported MANE shares worth $4.2B at the end of Q2 2026, about 92% of the company. The largest holder is Montanova Capital, LLC with 11.2%.

Funds and institutions (13F) 92%Everyone else 8%

10 largest owners, by share of the company

Montanova Capital, LLC11.2%
FMR LLC (Fidelity)8.6%
SR One Capital Management, LP6.4%
Deep Track Capital, LP5.4%
Citadel Advisors LLC5.0%
Siren, L.L.C.4.4%
BlackRock, Inc.4.3%
Viking Global Investors LP4.2%
JPMorgan Chase & Co3.1%
Aberdeen Group plc2.9%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Montanova Capital, LLC4.17M11.16%$513MNo change
FMR LLC (Fidelity)3.20M8.58%$394M+79%
SR One Capital Management, LP2.40M6.43%$295MNo change
Deep Track Capital, LP2.00M5.36%$246M+300%
Citadel Advisors LLC1.88M5.03%$231M+3%
Siren, L.L.C.1.66M4.43%$204M+10%
BlackRock, Inc.1.59M4.27%$196M+464%
Viking Global Investors LP1.56M4.18%$192M-8%
JPMorgan Chase & Co1.17M3.12%$144MNew
Aberdeen Group plc1.10M2.94%$135M+4%
D. E. Shaw & Co., Inc.1.01M2.71%$125M+655%
Vanguard Capital Management LLC869,2122.33%$107M+24%
Maverick Capital Ltd789,9802.12%$97.1MNew
Jennison Associates LLC748,6782.01%$92M+428%
Infinitum Asset Management, LLC731,1491.96%$89.9MNo change
UBS Group AG670,7271.80%$82.5M+93%
Marshall Wace, LLP585,5601.57%$72M-11%
Adage Capital Partners Gp, L.l.c.549,7061.47%$67.6M-50%
State Street Corp544,3691.46%$66.9M+632%
Geode Capital Management, LLC508,0671.36%$62.5M+185%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, MANE insiders reported $34.8M of open-market purchases and $141M of sales. 9% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$34.8M
23 trades, 4 people
Sales, 12 months
$141M
16 trades, 5 people
Sales under a 10b5-1 plan
9%
Share of sale value
Latest trade
Nov 11, 2026
Filed Nov 13, 2026

Purchases and sales by month

$103M$103MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 11, 2026Patrick G EnrightDirectorSale250,000$150.38$37.6MForm 4
Aug 19, 2026Averill Master Fund, Ltd. +3DirectorSale690,601$107.25$74.1MForm 4
Aug 19, 2026Averill Master Fund, Ltd. +3DirectorSale59,399$107.25$6.4MForm 4
Aug 17, 2026Timothy August DursoChief Technical OfficerSale plan161$111.28$17.9KForm 4
Aug 17, 2026Timothy August DursoChief Technical OfficerSale plan7,918$106.71$845KForm 4
Aug 17, 2026Timothy August DursoChief Technical OfficerSale plan16,306$107.52$1.8MForm 4
Aug 17, 2026Timothy August DursoChief Technical OfficerSale plan16,767$108.38$1.8MForm 4
Aug 17, 2026Timothy August DursoChief Technical OfficerSale plan2,348$109.34$257KForm 4
Aug 17, 2026Reid Alexander WaldmanCEOSale plan11,527$106.72$1.2MForm 4
Aug 17, 2026Reid Alexander WaldmanCEOSale plan25,234$107.53$2.7MForm 4
Aug 17, 2026Reid Alexander WaldmanCEOSale plan27,490$108.45$3MForm 4
Aug 17, 2026Reid Alexander WaldmanCEOSale plan3,000$109.38$328KForm 4
Aug 17, 2026Reid Alexander WaldmanCEOSale plan249$111.28$27.7KForm 4
Aug 12, 2026John W ChildsDirectorSale15,000$106.14$1.6MForm 4
Aug 12, 2026John W ChildsDirectorSale5,000$108.24$541KForm 4
Aug 12, 2026John W ChildsDirectorSale80,000$107.23$8.6MForm 4
Feb 6, 2026Suvretta Capital Management, Llc +3DirectorPurchase11,183$35.97$402KForm 4
Feb 6, 2026Suvretta Capital Management, Llc +3DirectorPurchase19,338$36.55$707KForm 4
Feb 5, 2026John W ChildsDirectorPurchase294,117$17.00$5MForm 4
Feb 5, 2026Suvretta Capital Management, Llc +3DirectorPurchase3,832$36.07$138KForm 4
Feb 5, 2026Suvretta Capital Management, Llc +3DirectorPurchase19,199$36.93$709KForm 4
Feb 5, 2026Suvretta Capital Management, Llc +3DirectorPurchase38,771$37.63$1.5MForm 4
Feb 5, 2026Suvretta Capital Management, Llc +3DirectorPurchase17,835$38.67$690KForm 4
Feb 5, 2026Suvretta Capital Management, Llc +3DirectorPurchase16,563$39.80$659KForm 4
Feb 5, 2026Vlad CoricDirectorPurchase58,823$17.00$1000KForm 4
Feb 5, 2026Longitude Venture Partners V, L.P. +310% ownerPurchase192,647$17.00$3.3MForm 4
Feb 5, 2026Longitude Venture Partners V, L.P. +310% ownerPurchase882,353$17.00$15MForm 4
Feb 4, 2026Suvretta Capital Management, Llc +3DirectorPurchase3,178$38.90$124KForm 4
Feb 4, 2026Suvretta Capital Management, Llc +3DirectorPurchase10,004$34.25$343KForm 4
Feb 4, 2026Suvretta Capital Management, Llc +3DirectorPurchase10,676$34.74$371KForm 4
Feb 4, 2026Suvretta Capital Management, Llc +3DirectorPurchase14,659$36.27$532KForm 4
Feb 4, 2026Suvretta Capital Management, Llc +3DirectorPurchase53,344$37.11$2MForm 4
Feb 4, 2026Suvretta Capital Management, Llc +3DirectorPurchase25,908$38.09$987KForm 4
Feb 4, 2026Suvretta Capital Management, Llc +3DirectorPurchase18,489$38.90$719KForm 4
Feb 4, 2026Suvretta Capital Management, Llc +3DirectorPurchase1,720$34.25$58.9KForm 4
Feb 4, 2026Suvretta Capital Management, Llc +3DirectorPurchase1,835$34.74$63.7KForm 4
Feb 4, 2026Suvretta Capital Management, Llc +3DirectorPurchase2,519$36.27$91.4KForm 4
Feb 4, 2026Suvretta Capital Management, Llc +3DirectorPurchase9,168$37.11$340KForm 4
Feb 4, 2026Suvretta Capital Management, Llc +3DirectorPurchase4,453$38.09$170KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Averill Master Fund, Ltd.Director–$80.4MAug 19, 2026
Patrick G EnrightDirector–$37.6MNov 11, 2026
Longitude Venture Partners V, L.P.10% owner$18.3M–Feb 5, 2026
John W ChildsDirector$5M$10.7MAug 12, 2026
Suvretta Capital Management, LlcDirector, 10% owner$10.5M–Feb 6, 2026
Reid Alexander WaldmanChief Executive Officer, Director–$7.3MAug 17, 2026
Timothy August DursoChief Technical Officer–$4.7MAug 17, 2026
Vlad CoricDirector$1000K–Feb 5, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

MANE short interest

Moderate short interest. 8.1% of MANE shares are sold short: about 1 share in 12. Over the last 12 reports the number of shares short went up 65%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 3.39M MANE shares were sold short, 8.1% of the shares outstanding, down 8.4% from the report before. At the average daily volume of 670,314 shares, buying them all back would take about 5.1 trading days (days to cover).

Shares short, % of all shares

8.11%May 15Oct 3014.0%

Days to cover

5.1May 15Oct 308.1

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20263.39M8.11%-8%670,3145.1
Oct 15, 20263.70M8.85%-13%982,2323.8
Sep 30, 20264.24M10.16%+3%907,0334.7
Sep 15, 20264.11M9.83%+2%549,3957.5
Aug 31, 20264.03M9.63%+0%608,6746.6
Aug 14, 20264.01M9.60%-17%1.00M4.0
Jul 31, 20264.82M12.91%+22%696,5456.9
Jul 15, 20263.94M10.54%+3%560,6257.0
Jun 30, 20263.81M10.20%+53%1.07M3.5
Jun 15, 20262.49M6.68%+5%418,0006.0
May 29, 20262.36M6.33%+15%489,8994.8
May 15, 20262.05M5.49%-0%632,1503.2

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Veradermics company events

Veradermics filed 11 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Nov 10, 2026.

  1. Nov 10, 2026ResultsReleased financial results. Filing
  2. Nov 9, 2026AnnouncementThe Company announced positive topline results from Part B of its randomized, double-blind, placebo-controlled, registration-directed Phase 2/3 clinical trial (Study ‘302’) evaluating VDPHL01, an investigational, proprietary, extended-release oral minoxidil formulation, in over 500 males with… Filing
  3. Oct 19, 2026AnnouncementThe Company announced positive topline data from the Phase 3 clinical trial, Study ‘304’ evaluating VDPHL01 in males with mild-to-moderate pattern hair loss. Filing
  4. Aug 11, 2026ResultsReleased financial results. Filing
  5. Jul 15, 2026AnnouncementThe Company announced positive topline results from Study ‘207’ evaluating VDPHL01, a proprietary extended-release oral minoxidil formulation, in females with mild-to-moderate pattern hair loss. Filing
  6. May 12, 2026ResultsReleased financial results. Filing
  7. May 1, 2026AgreementVeradermics, Incorporated closed its underwritten public offering of 3,843,790 shares of the Company’s common stock, par value $0.00001 per share, at a public offering price of $100.00 per share, pursuant to the Company’s registration statements on Form S-1 (File Nos. 333-295356 and 333-295420). Filing
  8. Apr 27, 2026ResultsReleased financial results. Filing
  9. Apr 27, 2026AnnouncementThe Company announced positive topline data from the Phase 2/3 clinical trial, Study ‘302’ evaluating VDPHL01 in males with mild-to-moderate pattern hair loss. Filing
  10. Mar 30, 2026ResultsReleased financial results. Filing
  11. Feb 5, 2026RulesChanged its bylaws or articles. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Veradermics financials

Famous investors that hold MANE

4 of the 50 well-known investors we track reported holding MANE in their latest 13F filing. The largest position is Ken Griffin's, worth $248M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 20262.05M$248M0.1%+9%
Lee Ainslie · Maverick CapitalQ3 2026941,846$114M0.9%+19%
Jim Simons · Renaissance TechnologiesQ3 2026149,352$18.1M0.0%+82%
Israel Englander · Millennium ManagementQ3 20264,390$532K0.0%-91%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named MANE in the last 120 days.

FiledHolderFormStake
Nov 13, 2026Longitude Capital Partners V, LLC13D/A5.6%
Nov 13, 2026Longitude Capital Partners V, LLC13D/A5.6%
Oct 13, 2026JPMORGAN CHASE & CO.13G5.6%
Oct 13, 2026JPMORGAN CHASE & CO.13G5.6%

Questions about Veradermics, Inc (MANE) stock

Who owns the most MANE stock?

The largest reported owner of Veradermics, Inc (MANE) is Montanova Capital, LLC, with 11.2% of the company. In total, 164 funds and institutions reported holding MANE at the end of Q2 2026, together about 92% of the shares. See the largest owners.

Are MANE insiders buying or selling?

In the last 12 months, MANE insiders reported 23 open-market purchases worth $34.8M and 16 sales worth $141M. The latest trade was on Nov 11, 2026. See every trade.

What is the short interest in MANE?

As of Oct 30, 2026, 3.39M MANE shares were sold short, 8.1% of the shares outstanding, down 8.4% from the report before. At the average daily volume of 670,314 shares, buying them all back would take about 5.1 trading days (days to cover). See the history.

Which famous investors hold MANE?

4 of the 50 well-known investors we track reported MANE in their latest 13F filing, including Ken Griffin, Lee Ainslie, Jim Simons. The largest position is worth $248M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.